FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Manuel Bartolomé

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Concepts & Ideas

Geographic Areas

Spain

Physiology

Procedures

Co-author Network

Publications

TOP 3
Carol Aristimuño; Clara de Andrés; Manuel Bartolomé; Virginia de Las Heras; Ma Luisa Martínez-Ginés; Rafael Arroyo; Eduardo Fernández-Cruz; Silvia Sánchez-Ramón
IFNbeta-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: a longitudinal 1-year study.
M D C Cénit; F Blanco-Kelly; Virginia de Las Heras; Manuel Bartolomé; E G de la Concha; Elena Urcelay; Rafael Arroyo; Alfonso Martínez
Glypican 5 is an interferon-beta response gene: a replication study.
Clara de Andrés; Carol Aristimuño; Manuel Bartolomé; Virginia de Las Heras; Ma Luisa Martínez-Ginés; Rafael Arroyo; Eduardo Fernández-Cruz; Silvia Sánchez-Ramón
Clinical response to interferon-beta-1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells Differential role of circulating dendritic cells and CD4+ regulatory T-cells in relapsing-remitting multiple sclerosis: a 1-year longitudinal study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Manuel Bartolomé (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Carol Aristimuño; Clara de Andrés; Manuel Bartolomé; Virginia de Las Heras; Ma Luisa Martínez-Ginés; Rafael Arroyo; Eduardo Fernández-Cruz; Silvia Sánchez-Ramón
IFNbeta-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: a longitudinal 1-year study.
Clinical immunology (Orlando, Fla.) 2010;134(2):148-57.
2009: M D C Cénit; F Blanco-Kelly; Virginia de Las Heras; Manuel Bartolomé; E G de la Concha; Elena Urcelay; Rafael Arroyo; Alfonso Martínez
Glypican 5 is an interferon-beta response gene: a replication study.
Multiple sclerosis (Houndmills, Basingstoke, England) 2009;15(8):913-7.
2009: Clara de Andrés; Carol Aristimuño; Manuel Bartolomé; Virginia de Las Heras; Ma Luisa Martínez-Ginés; Rafael Arroyo; Eduardo Fernández-Cruz; Silvia Sánchez-Ramón
Clinical response to interferon-beta-1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells Differential role of circulating dendritic cells and CD4+ regulatory T-cells in relapsing-remitting multiple sclerosis: a 1-year longitudinal study.
Journal of neuroimmunology 2009;212(1-2):112-20.
2007: Alfonso Martínez; Ana Mas; Virginia de Las Heras; Manuel Bartolomé; Rafael Arroyo; Miguel Fernández-Arquero; Emilio G De-la-Concha; Elena Urcelay
FcRL3 and multiple sclerosis pathogenesis: role in autoimmunity?
Journal of neuroimmunology 2007;189(1-2):132-6.
2007: Alfonso Martínez; Roberto Alvarez-Lafuente; Ana Mas; Manuel Bartolomé; Marta García-Montojo; Virginia de Las Heras; Emilio G De-la-Concha; Rafael Arroyo; Elena Urcelay
Environment-gene interaction in multiple sclerosis: human herpesvirus 6 and MHC2TA.
Human immunology 2007;68(8):685-9.
2007: Roberto Alvarez-Lafuente; Marta García-Montojo; Virginia de Las Heras; Manuel Bartolomé; Rafael Arroyo
JC virus in cerebrospinal fluid samples of multiple sclerosis patients at the first demyelinating event.
Multiple sclerosis (Houndmills, Basingstoke, England) 2007;13(5):590-5.
2007: Roberto Alvarez-Lafuente; Virginia de Las Heras; Marta García-Montojo; Manuel Bartolomé; Rafael Arroyo
Human herpesvirus-6 and multiple sclerosis: relapsing-remitting versus secondary progressive.
Multiple sclerosis (Houndmills, Basingstoke, England) 2007;13(5):578-83.
2007: Ana Mas; Alfonso Martínez; Virginia de Las Heras; Manuel Bartolomé; Emilio G De-la-Concha; Rafael Arroyo; Elena Urcelay
The 795CT polymorphism in osteopontin gene is not associated with multiple sclerosis in a Spanish population.
Multiple sclerosis (Houndmills, Basingstoke, England) 2007;13(2):250-2.
2007: Roberto Alvarez-Lafuente; Marta García-Montojo; Virginia de Las Heras; Manuel Bartolomé; Rafael Arroyo
Interferon-beta treatment and active replication of the JC virus in relapsing-remitting multiple sclerosis patients.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2007;14(2):233-6.
2007: Clara de Andrés; Carol Aristimuño; Virginia de Las Heras; Ma Luisa Martínez-Ginés; Manuel Bartolomé; Rafael Arroyo; Joaquín Navarro; Santiago Giménez-Roldán; Eduardo Fernández-Cruz; Silvia Sánchez-Ramón
Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis.
Journal of neuroimmunology 2007;182(1-2):204-11.
2006: Roberto Alvarez-Lafuente; Marta García-Montojo; Virginia de Las Heras; Manuel Bartolomé; Rafael Arroyo
Clinical parameters and HHV-6 active replication in relapsing-remitting multiple sclerosis patients.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;37 Suppl 1():S24-6.
2006: Alfonso Martínez; Virginia de Las Heras; Ana Mas-Fontao; Manuel Bartolomé; Emilio G De-la-Concha; Elena Urcelay; Rafael Arroyo
An IFNG polymorphism is associated with interferon-beta response in Spanish MS patients.
Journal of neuroimmunology 2006;173(1-2):196-9.
2006: Roberto Alvarez-Lafuente; Virginia de Las Heras; Manuel Bartolomé; Marta García-Montojo; Rafael Arroyo
Human herpesvirus 6 and multiple sclerosis: a one-year follow-up study.
Brain pathology (Zurich, Switzerland) 2006;16(1):20-7.
2004: Roberto Alvarez-Lafuente; Virginia de Las Heras; Manuel Bartolomé; Juan J Picazo; Rafael Arroyo
Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection.
Archives of neurology 2004;61(10):1523-7.
2004: Roberto Alvarez-Lafuente; Virginia de Las Heras; Manuel Bartolomé; Juan J Picazo; Rafael Arroyo
Beta-interferon treatment reduces human herpesvirus-6 viral load in multiple sclerosis relapses but not in remission.
European neurology 2004;52(2):87-91.